Global Trends in Diabetes Management: A report by the World Health Organization on global diabetes trends provided a broader context for understanding the significance of semaglutide and similar medications in addressing a major public health challenge
Methods A systematic literature search was conducted on PubMed and Embase (Ovid) databases using the search terms GLP-1 and pain
Comparative Trials of Glucagon-Like Peptide-1 Inhibitors and ActRII Inhibitors Clinical trials comparing GLP-1 RAs like semaglutide and dual incretin agonists (GLP-1RA/GIP) like tirzepatide, alone or in combination with myostatin inhibitors (bimagrumab, trevogrumab, and garetosmab), demonstrate varying effects on weight loss, body composition, and physical function in obese populations , (Table 2)
On the other hand, the risks of HHF (HR 0.93, 95% CI 0.831.04 with GLP-1RAs and HR 0.69, 95% CI 0.610.79 with SGLT2is) and composite kidney outcomes excluding macroalbuminuria (HR 0.92, 95% CI 0.801.06 with GLP-1RAs and HR 0.55, 95% CI 0.480.64 with SGLT2is) significantly reduced with SGLT2is only
While some patients are able to get enough B12 through their consumption of red meats, dairy products, and fish, other patients find their dietary restrictions or metabolism limit the amount of B12 they receive